KILITCH DRUGS (INDIA)
|
The Current P/E Ratio of KILITCH DRUGS (INDIA) is 44.18.
Share Price | ₹351.2 | Apr 18,2024 |
Market Cap | ₹565.4 Cr | |
Earnings-TTM | ₹12.8 Cr | TTM-Consolidated Results |
Price/Earnings | 44.18x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of KILITCH DRUGS (INDIA)
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹565.4 Cr] as on Apr 18,2024
(/) Earnings [ ₹12.8 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 44.18x ]
Thus, for KILITCH DRUGS (INDIA) , the investors are currently willing to pay 44.18 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KILITCH DRUGS (INDIA) !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of KILITCH DRUGS (INDIA) over the last five years.
Historical PE (Price/Earnings) ratio chart of KILITCH DRUGS (INDIA)
PE Ratio Performance Analysis for KILITCH DRUGS (INDIA)
- KILITCH DRUGS (INDIA) 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 63.74x.
- KILITCH DRUGS (INDIA) 's operated at median p/e ratio of 35.47x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KILITCH DRUGS (INDIA) 's p/e ratio peaked in Mar2020 at 148.95x.
- KILITCH DRUGS (INDIA) 's p/e ratio hit its five-year low in Mar2023 of 20.81x.
How does KILITCH DRUGS (INDIA) 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
KILITCH DRUGS (INDIA) | 12.80 | 44.18 | 565.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.45 | 364,015.0 |
CIPLA LTD | 3,744.03 | 29.06 | 108,809.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 19.08 | 99,408.7 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 31.89 | 94,213.7 |
DIVIS LABORATORIES LTD | 1,382.97 | 71.36 | 98,684.0 |
MANKIND PHARMA LTD | 1,743.30 | 55.09 | 96,037.1 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 57.71 | 86,219.0 |
LUPIN LTD | 1,809.74 | 40.13 | 72,621.1 |
AUROBINDO PHARMA LTD | 2,777.89 | 23.52 | 65,326.3 |
ABBOTT INDIA LTD | 1,145.58 | 48.33 | 55,366.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KILITCH DRUGS (INDIA) 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.08x |
Max industry PE | 71.36x |
Median industry PE | 40.45x |
Average industry PE | 41.89x |
You may also like the below Video Courses